25 XP   0   0   10

Forte Biosciences Inc
Buy, Hold or Sell?

Let's analyse Forte Biosciences Inc together

PenkeI guess you are interested in Forte Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Forte Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Forte Biosciences Inc

I send you an email if I find something interesting about Forte Biosciences Inc.

Quick analysis of Forte Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Forte Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.97
Expected worth in 1 year
$0.87
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
$-0.10
Return On Investment
-12.3%

For what price can you sell your share?

Current Price per Share
$0.78
Expected price per share
$0.62 - $0.85
How sure are you?
50%

1. Valuation of Forte Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.78

Intrinsic Value Per Share

$-10.30 - $-12.20

Total Value Per Share

$-9.33 - $-11.23

2. Growth of Forte Biosciences Inc (5 min.)




Is Forte Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$35.3m$39.9m-$6.5m-19.7%

How much money is Forte Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.8m-$3.4m-$4.3m-55.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Forte Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#522 / 1016

Most Revenue
#910 / 1016

Most Profit
#509 / 1016

Most Efficient
#357 / 1016

What can you expect buying and holding a share of Forte Biosciences Inc? (5 min.)

Welcome investor! Forte Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Forte Biosciences Inc.

What can you expect buying and holding a share of Forte Biosciences Inc?

First you should know what it really means to hold a share of Forte Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Forte Biosciences Inc is $0.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Forte Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Forte Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.97. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Forte Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-20.7%-0.21-27.4%-0.10-12.2%-0.22-27.9%-0.20-25.4%
Usd Book Value Change Per Share-0.10-12.4%-0.02-3.1%-0.02-2.4%0.056.2%0.045.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-12.4%-0.02-3.1%-0.02-2.4%0.056.2%0.045.7%
Usd Price Per Share0.82-0.88-1.21-10.04-9.67-
Price to Earnings Ratio-1.27--1.08--3.45--16.58--223.19-
Price-to-Total Gains Ratio-8.48--4.43--15.44--51.96-103.81-
Price to Book Ratio0.85-1.03-1.10-11.53-190.15-
Price-to-Total Gains Ratio-8.48--4.43--15.44--51.96-103.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.78
Number of shares1282
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.05
Usd Total Gains Per Share-0.020.05
Gains per Quarter (1282 shares)-30.8662.00
Gains per Year (1282 shares)-123.43248.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-123-1330248238
20-247-2560496486
30-370-3790744734
40-494-5020992982
50-617-625012401230
60-741-748014881478
70-864-871017361726
80-987-994019841974
90-1111-1117022322222
100-1234-1240024802470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.022.00.00.0%0.022.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%6.016.00.027.3%6.016.00.027.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.022.00.0%0.00.022.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%6.016.00.027.3%6.016.00.027.3%

Fundamentals of Forte Biosciences Inc

About Forte Biosciences Inc

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Fundamental data was last updated by Penke on 2024-04-11 07:41:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Forte Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Forte Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Forte Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-17,242.8%+17,242.8%
5Y-17,242.8%10Y-15,675.3%-1,567.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y-17,242.8%-438.4%-16,804.4%
10Y-15,675.3%-605.5%-15,069.8%
1.1.2. Return on Assets

Shows how efficient Forte Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • -15.1% Return on Assets means that Forte Biosciences Inc generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Forte Biosciences Inc:

  • The MRQ is -15.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-20.6%+5.6%
TTM-20.6%YOY-8.3%-12.3%
TTM-20.6%5Y-19.0%-1.6%
5Y-19.0%10Y-19.2%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.1%-13.5%-1.6%
TTM-20.6%-12.9%-7.7%
YOY-8.3%-11.8%+3.5%
5Y-19.0%-14.1%-4.9%
10Y-19.2%-16.0%-3.2%
1.1.3. Return on Equity

Shows how efficient Forte Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • -16.6% Return on Equity means Forte Biosciences Inc generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Forte Biosciences Inc:

  • The MRQ is -16.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.6%TTM-24.3%+7.7%
TTM-24.3%YOY-8.7%-15.6%
TTM-24.3%5Y-29.5%+5.2%
5Y-29.5%10Y-27.8%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.6%-16.9%+0.3%
TTM-24.3%-16.1%-8.2%
YOY-8.7%-15.1%+6.4%
5Y-29.5%-19.9%-9.6%
10Y-27.8%-20.9%-6.9%

1.2. Operating Efficiency of Forte Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Forte Biosciences Inc is operating .

  • Measures how much profit Forte Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Forte Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-17,541.7%+17,541.7%
5Y-17,541.7%10Y-15,947.0%-1,594.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y-17,541.7%-477.4%-17,064.3%
10Y-15,947.0%-625.6%-15,321.4%
1.2.2. Operating Ratio

Measures how efficient Forte Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Forte Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y163.844-163.844
5Y163.84410Y148.949+14.895
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y163.8445.679+158.165
10Y148.9497.894+141.055

1.3. Liquidity of Forte Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Forte Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.45 means the company has $10.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Forte Biosciences Inc:

  • The MRQ is 10.455. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.822. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.455TTM7.822+2.633
TTM7.822YOY22.589-14.767
TTM7.8225Y12.826-5.004
5Y12.82610Y11.952+0.874
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4553.914+6.541
TTM7.8224.220+3.602
YOY22.5895.388+17.201
5Y12.8266.045+6.781
10Y11.9526.406+5.546
1.3.2. Quick Ratio

Measures if Forte Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 16.99 means the company can pay off $16.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Forte Biosciences Inc:

  • The MRQ is 16.991. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.622. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ16.991TTM10.622+6.369
TTM10.622YOY22.373-11.751
TTM10.6225Y13.617-2.995
5Y13.61710Y12.872+0.744
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.9913.572+13.419
TTM10.6223.998+6.624
YOY22.3735.390+16.983
5Y13.6175.969+7.648
10Y12.8726.287+6.585

1.4. Solvency of Forte Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Forte Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Forte Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Forte Biosciences Inc assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Forte Biosciences Inc:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.139. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.139-0.045
TTM0.139YOY0.049+0.090
TTM0.1395Y0.228-0.089
5Y0.22810Y0.265-0.038
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.336-0.242
TTM0.1390.334-0.195
YOY0.0490.269-0.220
5Y0.2280.366-0.138
10Y0.2650.390-0.125
1.4.2. Debt to Equity Ratio

Measures if Forte Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.4% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Forte Biosciences Inc:

  • The MRQ is 0.104. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.164. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.164-0.060
TTM0.164YOY0.052+0.112
TTM0.1645Y0.798-0.634
5Y0.79810Y0.740+0.058
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1040.382-0.278
TTM0.1640.396-0.232
YOY0.0520.335-0.283
5Y0.7980.434+0.364
10Y0.7400.465+0.275

2. Market Valuation of Forte Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Forte Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -1.27 means the investor is paying $-1.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Forte Biosciences Inc:

  • The EOD is -1.209. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.274. Based on the earnings, the company is expensive. -2
  • The TTM is -1.082. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.209MRQ-1.274+0.065
MRQ-1.274TTM-1.082-0.192
TTM-1.082YOY-3.450+2.368
TTM-1.0825Y-16.584+15.502
5Y-16.58410Y-223.190+206.606
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.209-2.259+1.050
MRQ-1.274-2.569+1.295
TTM-1.082-2.664+1.582
YOY-3.450-4.120+0.670
5Y-16.584-6.258-10.326
10Y-223.190-6.171-217.019
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Forte Biosciences Inc:

  • The EOD is -0.790. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.832. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.253. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.790MRQ-0.832+0.043
MRQ-0.832TTM-1.253+0.421
TTM-1.253YOY-5.870+4.617
TTM-1.2535Y-19.780+18.526
5Y-19.78010Y-225.323+205.543
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.790-2.924+2.134
MRQ-0.832-3.246+2.414
TTM-1.253-3.488+2.235
YOY-5.870-5.620-0.250
5Y-19.780-8.315-11.465
10Y-225.323-8.826-216.497
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Forte Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.85 means the investor is paying $0.85 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Forte Biosciences Inc:

  • The EOD is 0.804. Based on the equity, the company is cheap. +2
  • The MRQ is 0.847. Based on the equity, the company is cheap. +2
  • The TTM is 1.026. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.804MRQ0.847-0.043
MRQ0.847TTM1.026-0.179
TTM1.026YOY1.103-0.077
TTM1.0265Y11.534-10.508
5Y11.53410Y190.150-178.616
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8041.851-1.047
MRQ0.8472.090-1.243
TTM1.0262.095-1.069
YOY1.1032.844-1.741
5Y11.5343.466+8.068
10Y190.1503.815+186.335
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Forte Biosciences Inc.

3.1. Institutions holding Forte Biosciences Inc

Institutions are holding 56.168% of the shares of Forte Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Tybourne Capital Management (HK) Ltd9.990.4438362454800
2023-12-31Perceptive Advisors LLC90.0599326535900
2023-09-30Bvf Inc8.21930.0532298210529821050
2023-12-31Cable Car Capital LLC5.60061.7336203198720319870
2023-12-31Fred Alger Management, LLC5.06860.0082183896500
2023-12-31Farallon Capital Management, L.L.C.4.990.0074181045500
2023-12-31BML Capital Management LLC4.85561.0965176170200
2023-12-31Vanguard Group Inc1.833506652304000.0602
2023-12-31Geode Capital Management, LLC0.9278033660512822261.5319
2023-12-31BlackRock Inc0.502501823241600.0878
2023-12-31Renaissance Technologies Corp0.35780.000212980029002.2853
2023-12-31State Street Corporation0.114804166400
2023-12-31Goldman Sachs Group Inc0.1143041480772422.8819
2023-12-31Two Sigma Investments LLC0.11290.000140964-400-0.967
2023-12-31Northern Trust Corp0.074202691100
2023-12-31Two Sigma Advisers, LLC0.06830.000124791-2200-8.1509
2023-12-31Group One Trading, LP0.043601582700
2023-12-31TWO SIGMA SECURITIES, LLC0.04250.000115432154320
2023-12-31Aries Wealth Management0.03580.00381300000
2023-09-30JANE STREET GROUP, LLC0.0297010763107630
Total 51.98183.406918859912+5177093+27.5%

3.2. Funds holding Forte Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Alger Health Sciences A3.28290.8633119284200
2023-12-31Alger LIfe Sciences Innovation Composite1.77822.863564612300
2024-02-29Vanguard Total Stock Mkt Idx Inv1.3415048742900
2024-01-31Fidelity Extended Market Index0.51010.000318534400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.41140.000114948400
2024-02-29Fidelity Nasdaq Composite ETF0.340.0014123547-260-0.21
2023-09-30BlackRock Extended Mkt Composite0.08580.00023116400
2023-12-31BlackRock Extended Equity Market K0.07480.000227188-55-0.2019
2024-02-29Vanguard U.S. Eq Idx £ Acc0.06320.00012296900
2024-01-31Fidelity Total Market Index0.045801663800
2023-12-31Northern Trust Extended Eq Market Idx0.04460.00021619100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04460.00021619100
2024-01-31Fidelity Series Total Market Index0.0367013322255223.6955
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0260.0001944200
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02090.00017583140.185
2024-02-29iShares Core S&P Total US Stock Mkt ETF0.02060749900
2024-02-29Vanguard Balanced Index Inv0.01470534800
2023-12-31SSgA U.S. Extended Market Index Class I0.01130.0001410600
2024-02-29State St US Extended Mkt Indx NL Cl C0.01130.0002410600
2024-01-31Spartan Total Market Index Pool E0.01090397800
Total 8.17533.732970494+2251+0.1%

3.3. Insider Transactions

Insiders are holding 10.828% of the shares of Forte Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-18Paul A WagnerBUY100000.75
2023-12-13Paul A WagnerBUY105200.7
2023-12-11Paul A WagnerBUY250000.65
2023-12-07Paul A WagnerBUY362030.58
2023-11-22Paul A WagnerBUY4000.43
2023-11-20Paul A WagnerBUY69660.44

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Forte Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.097-0.024-75%-0.019-81%0.048-300%0.044-320%
Book Value Per Share--0.9700.907+7%1.098-12%0.962+1%0.874+11%
Current Ratio--10.4557.822+34%22.589-54%12.826-18%11.952-13%
Debt To Asset Ratio--0.0940.139-32%0.049+93%0.228-59%0.265-65%
Debt To Equity Ratio--0.1040.164-37%0.052+101%0.798-87%0.740-86%
Dividend Per Share----0%-0%-0%-0%
Eps---0.161-0.214+32%-0.095-41%-0.218+35%-0.198+23%
Free Cash Flow Per Share---0.247-0.195-21%-0.056-77%-0.164-34%-0.149-40%
Free Cash Flow To Equity Per Share---0.249-0.032-87%-0.006-97%-0.039-84%-0.035-86%
Gross Profit Margin--1.0011.000+0%1.000+0%1.007-1%1.006-1%
Intrinsic Value_10Y_max---12.197--------
Intrinsic Value_10Y_min---10.301--------
Intrinsic Value_1Y_max---0.595--------
Intrinsic Value_1Y_min---0.584--------
Intrinsic Value_3Y_max---2.265--------
Intrinsic Value_3Y_min---2.153--------
Intrinsic Value_5Y_max---4.512--------
Intrinsic Value_5Y_min---4.147--------
Market Cap28388022.000-5%29916607.80032397826.966-8%43946841.750-32%365487957.718-92%11054287750.198-100%
Net Profit Margin----0%-0%-172.4280%-156.7530%
Operating Margin----0%-0%-175.4170%-159.4700%
Operating Ratio----0%-0%163.844-100%148.949-100%
Pb Ratio0.804-5%0.8471.026-17%1.103-23%11.534-93%190.150-100%
Pe Ratio-1.209+5%-1.274-1.082-15%-3.450+171%-16.584+1202%-223.190+17423%
Price Per Share0.780-5%0.8220.884-7%1.208-32%10.041-92%9.667-91%
Price To Free Cash Flow Ratio-0.790+5%-0.832-1.253+51%-5.870+605%-19.780+2276%-225.323+26972%
Price To Total Gains Ratio-8.048+5%-8.481-4.428-48%-15.442+82%-51.956+513%103.813-108%
Quick Ratio--16.99110.622+60%22.373-24%13.617+25%12.872+32%
Return On Assets---0.151-0.206+37%-0.083-45%-0.190+26%-0.192+28%
Return On Equity---0.166-0.243+46%-0.087-47%-0.295+78%-0.278+67%
Total Gains Per Share---0.097-0.024-75%-0.019-81%0.048-300%0.044-320%
Usd Book Value--35314000.00033388500.000+6%39977000.000-12%35075700.000+1%34531090.909+2%
Usd Book Value Change Per Share---0.097-0.024-75%-0.019-81%0.048-300%0.044-320%
Usd Book Value Per Share--0.9700.907+7%1.098-12%0.962+1%0.874+11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.161-0.214+32%-0.095-41%-0.218+35%-0.198+23%
Usd Free Cash Flow---8986000.000-7198500.000-20%-2046250.000-77%-5977700.000-33%-6368272.727-29%
Usd Free Cash Flow Per Share---0.247-0.195-21%-0.056-77%-0.164-34%-0.149-40%
Usd Free Cash Flow To Equity Per Share---0.249-0.032-87%-0.006-97%-0.039-84%-0.035-86%
Usd Market Cap28388022.000-5%29916607.80032397826.966-8%43946841.750-32%365487957.718-92%11054287750.198-100%
Usd Price Per Share0.780-5%0.8220.884-7%1.208-32%10.041-92%9.667-91%
Usd Profit---5872000.000-7843500.000+34%-3482500.000-41%-7124300.000+21%-7474500.000+27%
Usd Revenue----0%-0%2250.000-100%2045.455-100%
Usd Total Gains Per Share---0.097-0.024-75%-0.019-81%0.048-300%0.044-320%
 EOD+3 -5MRQTTM+16 -14YOY+4 -265Y+15 -1710Y+14 -18

4.2. Fundamental Score

Let's check the fundamental score of Forte Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.209
Price to Book Ratio (EOD)Between0-10.804
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than116.991
Current Ratio (MRQ)Greater than110.455
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.104
Return on Equity (MRQ)Greater than0.15-0.166
Return on Assets (MRQ)Greater than0.05-0.151
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Forte Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.261
Ma 20Greater thanMa 500.715
Ma 50Greater thanMa 1000.696
Ma 100Greater thanMa 2000.683
OpenGreater thanClose0.769
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets38,980
Total Liabilities3,666
Total Stockholder Equity35,314
 As reported
Total Liabilities 3,666
Total Stockholder Equity+ 35,314
Total Assets = 38,980

Assets

Total Assets38,980
Total Current Assets38,327
Long-term Assets653
Total Current Assets
Cash And Cash Equivalents 11,961
Short-term Investments 25,164
Other Current Assets 1,202
Total Current Assets  (as reported)38,327
Total Current Assets  (calculated)38,327
+/-0
Long-term Assets
Property Plant Equipment 109
Long-term Assets Other 544
Long-term Assets  (as reported)653
Long-term Assets  (calculated)653
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,666
Long-term Liabilities0
Total Stockholder Equity35,314
Total Current Liabilities
Accounts payable 1,424
Other Current Liabilities 2,242
Total Current Liabilities  (as reported)3,666
Total Current Liabilities  (calculated)3,666
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock36
Retained Earnings -118,520
Accumulated Other Comprehensive Income 4
Other Stockholders Equity 153,794
Total Stockholder Equity (as reported)35,314
Total Stockholder Equity (calculated)35,314
+/-0
Other
Capital Stock36
Cash and Short Term Investments 37,125
Common Stock Shares Outstanding 36,335
Liabilities and Stockholders Equity 38,980
Net Debt -11,961
Net Invested Capital 35,314
Net Working Capital 34,661
Property Plant and Equipment Gross 118



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
34,294
110,770
102,170
92,073
78,739
87,336
90,353
103,081
94,728
85,234
70,749
28,160
18,632
28,311
22,730
61,239
57,068
52,887
47,390
43,306
41,304
39,720
45,128
41,997
36,708
31,184
47,879
38,980
38,98047,87931,18436,70841,99745,12839,72041,30443,30647,39052,88757,06861,23922,73028,31118,63228,16070,74985,23494,728103,08190,35387,33678,73992,073102,170110,77034,294
   > Total Current Assets 
30,038
109,595
100,811
90,629
77,118
83,450
85,083
97,748
81,689
72,789
59,543
22,956
14,509
28,144
21,617
59,898
55,872
51,881
46,556
42,520
40,411
38,846
44,594
41,511
36,271
30,747
47,102
38,327
38,32747,10230,74736,27141,51144,59438,84640,41142,52046,55651,88155,87259,89821,61728,14414,50922,95659,54372,78981,68997,74885,08383,45077,11890,629100,811109,59530,038
       Cash And Cash Equivalents 
6,955
76,106
74,842
35,933
17,793
24,613
23,482
40,813
30,998
18,898
25,580
8,986
14,232
27,749
20,175
58,765
54,762
50,795
45,665
42,044
40,035
38,548
44,048
41,100
35,902
20,438
21,144
11,961
11,96121,14420,43835,90241,10044,04838,54840,03542,04445,66550,79554,76258,76520,17527,74914,2328,98625,58018,89830,99840,81323,48224,61317,79335,93374,84276,1066,955
       Short-term Investments 
21,930
32,536
24,731
52,792
56,205
54,848
56,367
55,273
49,125
49,426
29,762
12,835
12,835
0
0
0
0
0
0
0
0
0
0
0
0
9,987
25,041
25,164
25,16425,0419,98700000000000012,83512,83529,76249,42649,12555,27356,36754,84856,20552,79224,73132,53621,930
       Other Current Assets 
1,153
953
1,238
1,904
3,120
3,989
5,234
1,662
1,566
4,465
4,201
1,135
277
160
464
76
144
139
119
88
89
94
119
70
109
129
94
1,202
1,2029412910970119948988119139144764641602771,1354,2014,4651,5661,6625,2343,9893,1201,9041,2389531,153
   > Long-term Assets 
4,256
1,175
1,359
1,444
1,621
3,886
5,270
5,333
13,039
12,445
11,206
5,204
4,123
167
1,113
1,341
1,196
1,006
834
786
893
874
534
486
437
437
777
653
6537774374374865348748937868341,0061,1961,3411,1131674,1235,20411,20612,44513,0395,3335,2703,8861,6211,4441,3591,1754,256
       Property Plant Equipment 
734
883
1,045
1,217
1,387
3,652
4,033
3,973
11,714
11,420
11,201
5,204
4,123
124
110
97
83
70
0
0
0
0
0
0
0
30
98
109
109983000000007083971101244,1235,20411,20111,42011,7143,9734,0333,6521,3871,2171,045883734
       Long-term Assets Other 
3,522
292
314
227
234
234
1,237
1,360
1,325
1,025
5
-12,835
-12,835
43
1,003
1,244
1,113
936
834
786
893
874
534
486
437
407
679
544
5446794074374865348748937868349361,1131,2441,00343-12,835-12,83551,0251,3251,3601,2372342342273142923,522
> Total Liabilities 
35,802
22,203
22,055
20,991
19,061
41,247
42,686
44,936
49,874
48,748
50,949
17,312
16,550
3,433
2,411
2,259
2,370
2,978
3,740
1,758
1,256
1,513
2,293
3,179
3,760
6,300
7,471
3,666
3,6667,4716,3003,7603,1792,2931,5131,2561,7583,7402,9782,3702,2592,4113,43316,55017,31250,94948,74849,87444,93642,68641,24719,06120,99122,05522,20335,802
   > Total Current Liabilities 
16,075
15,224
16,738
17,330
16,902
13,766
14,594
16,534
16,177
17,308
41,746
13,204
12,638
3,433
2,411
2,259
2,370
2,978
3,740
1,758
1,256
1,513
2,293
3,179
3,760
6,300
7,471
3,666
3,6667,4716,3003,7603,1792,2931,5131,2561,7583,7402,9782,3702,2592,4113,43312,63813,20441,74617,30816,17716,53414,59413,76616,90217,33016,73815,22416,075
       Short-term Debt 
7,200
7,200
7,200
7,200
7,200
0
0
0
2,204
4,408
27,843
4,744
4,981
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004,9814,74427,8434,4082,2040007,2007,2007,2007,2007,200
       Accounts payable 
947
1,265
1,154
1,951
1,784
1,500
4,555
3,404
2,786
2,501
2,293
3,218
1,627
2,567
1,513
1,240
1,206
985
2,330
946
576
698
1,191
1,153
1,342
3,006
5,354
1,424
1,4245,3543,0061,3421,1531,1916985769462,3309851,2061,2401,5132,5671,6273,2182,2932,5012,7863,4044,5551,5001,7841,9511,1541,265947
       Other Current Liabilities 
7,887
6,718
8,343
8,143
7,882
11,230
10,003
13,094
11,160
10,381
11,601
5,242
11,011
866
898
1,019
1,164
1,993
1,410
812
680
815
1,102
2,026
2,418
3,294
2,117
2,242
2,2422,1173,2942,4182,0261,1028156808121,4101,9931,1641,01989886611,0115,24211,60110,38111,16013,09410,00311,2307,8828,1438,3436,7187,887
   > Long-term Liabilities 
19,727
6,979
5,317
3,661
2,159
27,481
28,092
28,402
33,697
31,440
9,203
4,108
3,912
0
0
0
0
0
0
946
576
698
1,191
1,153
1,342
0
0
0
0001,3421,1531,1916985769460000003,9124,1089,20331,44033,69728,40228,09227,4812,1593,6615,3176,97919,727
       Long term Debt Total 
0
0
0
0
0
0
0
0
24,139
22,079
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000022,07924,13900000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106
106
262
291
0
0
0
0
0
0
000000291262106106000000000000000000
> Total Stockholder Equity
-1,508
88,567
80,115
71,082
59,678
46,089
47,667
58,145
44,854
36,486
19,800
10,848
2,082
24,878
20,319
58,980
54,698
49,909
43,650
41,548
40,048
38,207
42,835
38,818
32,948
24,884
40,408
35,314
35,31440,40824,88432,94838,81842,83538,20740,04841,54843,65049,90954,69858,98020,31924,8782,08210,84819,80036,48644,85458,14547,66746,08959,67871,08280,11588,567-1,508
   Common Stock
2
20
20
20
20
20
20
23
23
23
23
23
23
11
11
13
13
14
15
15
15
15
21
21
21
21
36
36
3636212121211515151514131311112323232323232020202020202
   Retained Earnings -118,520-112,648-102,693-93,797-87,044-82,167-78,767-75,732-73,165-69,824-62,073-56,261-51,457-46,881-41,781-289,680-279,400-268,817-250,082-232,968-215,884-196,281-195,898-179,809-166,929-156,092-146,139-137,073
   Capital Surplus 
0
0
0
0
0
0
0
0
277,781
286,489
288,551
290,215
291,739
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000291,739290,215288,551286,489277,78100000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
135,497
123,923
134,020
237,991
239,575
242,021
243,951
274,006
277,763
286,433
288,508
290,205
291,739
66,648
67,189
110,424
110,946
111,968
113,459
114,698
115,765
77,239
79,853
125,841
126,724
127,555
153,025
153,794
153,794153,025127,555126,724125,84179,85377,239115,765114,698113,459111,968110,946110,42467,18966,648291,739290,205288,508286,433277,763274,006243,951242,021239,575237,991134,020123,923135,497



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-9
Gross Profit-9-9
 
Operating Income (+$)
Gross Profit-9
Operating Expense-32,477
Operating Income-32,486-32,486
 
Operating Expense (+$)
Research Development21,862
Selling General Administrative10,624
Selling And Marketing Expenses9
Operating Expense32,47732,495
 
Net Interest Income (+$)
Interest Income1,124
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,124
 
Pretax Income (+$)
Operating Income-32,486
Net Interest Income1,124
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-31,476-33,496
EBIT - interestExpense = -32,486
-31,476
-31,476
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-32,486-31,476
Earnings Before Interest and Taxes (EBITDA)-32,477
 
After tax Income (+$)
Income Before Tax-31,476
Tax Provision-0
Net Income From Continuing Ops-30,481-31,476
Net Income-31,476
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses32,486
Total Other Income/Expenses Net1,010-1,124
 

Technical Analysis of Forte Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Forte Biosciences Inc. The general trend of Forte Biosciences Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Forte Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Forte Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.85 < 0.85 < 0.85.

The bearish price targets are: 0.779 > 0.765 > 0.62.

Tweet this
Forte Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Forte Biosciences Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Forte Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Forte Biosciences Inc. The current macd is 0.01475358.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Forte Biosciences Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Forte Biosciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Forte Biosciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Forte Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartForte Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Forte Biosciences Inc. The current adx is 13.96.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Forte Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Forte Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Forte Biosciences Inc. The current sar is 0.63977423.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Forte Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Forte Biosciences Inc. The current rsi is 64.26. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Forte Biosciences Inc Daily Relative Strength Index (RSI) ChartForte Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Forte Biosciences Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Forte Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Forte Biosciences Inc Daily Stochastic Oscillator ChartForte Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Forte Biosciences Inc. The current cci is 221.09.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Forte Biosciences Inc Daily Commodity Channel Index (CCI) ChartForte Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Forte Biosciences Inc. The current cmo is 41.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Forte Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartForte Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Forte Biosciences Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Forte Biosciences Inc Daily Williams %R ChartForte Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Forte Biosciences Inc.

Forte Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Forte Biosciences Inc. The current atr is 0.05176168.

Forte Biosciences Inc Daily Average True Range (ATR) ChartForte Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Forte Biosciences Inc. The current obv is 2,041,158.

Forte Biosciences Inc Daily On-Balance Volume (OBV) ChartForte Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Forte Biosciences Inc. The current mfi is 63.84.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Forte Biosciences Inc Daily Money Flow Index (MFI) ChartForte Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Forte Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Forte Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Forte Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.261
Ma 20Greater thanMa 500.715
Ma 50Greater thanMa 1000.696
Ma 100Greater thanMa 2000.683
OpenGreater thanClose0.769
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Forte Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Forte Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Forte Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Forte Biosciences Inc

I send you an email if I find something interesting about Forte Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Forte Biosciences Inc.

Receive notifications about Forte Biosciences Inc in your mailbox!